The difference between [18F]FDG SUVs for HER2-positive and negative lesions was not statistically significant either in the PET (P = 0.11) or SPECT study (P = 0.8) making tumour-to-reference calculations for HER2-expression irrelevant for [18F]FDG. Here, ERBB2 is linked to neoplasm.